sclerostin-inhibiting compounds (Yonsei University)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namesclerostin-inhibiting compounds (Yonsei University)

Drug Alias NameKDDF-201404-06

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSclerostin inhibitors

TargetsSclerostin

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesYonsei University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesYonsei University

Active IndicationsN/A

Inactive IndicationsOsteoporosis

ATC CodeN/A